About

Autologous Platelet-Derived Exosome-Rich Plasma

What is Exomine?

Exomine is the result of T-Lab’s continuous investment in research and innovation, providing a completely autologous method to harvest platelet-derived exosomes. The kit facilitates the release of billions of vesicles by causing stress to the platelets within PRP through a microlyzer cutting tool and uniquely designed PRF tube, making this a truly revolutionary exosome treatment.

Exomine achieves an approximate count of 4-5 billion vesicles per ml. With a final product size of approximately 5cc, Exomine delivers an industry-leading vesicle count, providing users an average of 25-30 billion vesicles.

This versatile product demonstrates efficacy across numerous diverse domains within the realm of medical aesthetics, including skin regeneration, hair loss treatments, spot treatments, joint and connective tissue therapies, and non-healing wounds.

1. mRNA: Through its support in transferring genetic information to the target cells, it plays a critical function in facilitating intercellular communication and the exchange of generic material
2. miRNA: Through the modulation of gene expression, it governs the synthesis of proteins, providing effective in biological processes such as cell differentiation, development and regulation
3. Protein: Provides intercellular communication and regulation

Safe and Effective

Exomine has evolved through years of extensive research and development, driven by T-Lab’s many years in regenerative medicine and autologous systems. Offering rapid and effective outcomes, Exomine provides users with an autologous and secure system. The fact that it is an autologous system obtained from the patient’s own blood eliminates the risk of allergic reactions after injection.

Billions of Vesicles

As a result of much research into optimum device and protocol options, Exomine achieved an approximate count of 4-5 billion vesicles per ml. With a final product size of approximately 5cc, Exomine delivers an industry-leading vesicle count, providing users an average of 25-30 billion vesicles.

To be defined as exosomes, vesicles need to be 30-150nm in size; be analysed with relevant CD markers; and exhibit high viability. Exomine studies show an average vesicle size of 116nm and a confirmation that 98% of vesicles are platelet-derived exosomes. (using the relevant CD markers) Impartial lab results further demonstrate a viability rate of 99%.

Application in Aesthetics

Exomine has broad uses in the fields of Aesthetics and Plastic Surgery, Dermatology and Medical Aesthetics. It is frequently employed in combination with tissue grafting to facilitate soft tissue healing, enhance regional tissue quality, achieve tissue radiance, increase elastic and collagen synthesis to reduce wrinkles, and address hair loss. In dermatology it is particularly utilised for skin rejuvenation, wrinkle reduction as well as the treatment of stretch marks and acne scars. Exomine also promotes the thickening of hair follicles in the effected area, aiding in root growth, making it a common post-hair transplant application for weakened hair.